| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $251.8M | -24.0% |
| Cost of Revenue | $68.6M | -21.3% |
| Gross Profit | $183.1M | -25.0% |
| R&D Expense | $97.8M | -19.6% |
| SG&A Expense | $48.8M | -7.0% |
| Operating Income | -$2.3M | +99.6% |
| Pre-tax Income | -$8.8M | +98.5% |
| Income Tax | $9.9M | +185.3% |
| Net Income | -$18.7M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Short-term Investments | $3.4M | -37.6% |
| Accounts Receivable | $58.9M | -6.1% |
| Inventory | $1.1M | +10.0% |
| Current Assets | $190.8M | -28.2% |
| Total Assets | $630.6M | -10.2% |
| Current Liabilities | $101.2M | -53.3% |
| Long-term Debt | $199.7M | -29.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $61.2M | +255.7% |
| Capital Expenditures | $14.4M | +187.3% |
| Investing Cash Flow | -$10.6M | -341.0% |
| Financing Cash Flow | -$87.0M | — |
| Free Cash Flow | $46.8M | +283.7% |
| +96.8% |
| EPS (Basic) | -$0.43 | +97.0% |
| EPS (Diluted) | -$0.43 | +97.0% |
| Total Liabilities |
| $479.9M |
| -14.5% |
| Stockholders' Equity | $150.7M | +6.8% |